Eisai
4523.T
#2008
Rank
ยฃ7.16 B
Marketcap
ยฃ25.41
Share price
-0.53%
Change (1 day)
11.97%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): ยฃ0.67

According to Eisai's latest financial reports the company's current EPS (TTM) is ยฃ0.66. In 2026 the company made an earnings per share (EPS) of ยฃ0.66 a decrease over its 2025 EPS that were of ยฃ0.84.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026ยฃ0.66-21.04%
2025ยฃ0.8411.85%
2024ยฃ0.75-32.63%
2023ยฃ1.115.52%
2022ยฃ1.05-74.01%
2021ยฃ4.04-66.58%
2020ยฃ12.0998.24%
2019ยฃ6.1017.01%
2018ยฃ5.2137.78%
2017ยฃ3.78-27.62%
2016ยฃ5.2335.33%
2015ยฃ3.86-2.82%
2014ยฃ3.97-27.66%
2013ยฃ5.49-27.49%
2012ยฃ7.58-12.67%
2011ยฃ8.6888.08%
2010ยฃ4.61-11.06%
2009ยฃ5.19-390.15%
2008-ยฃ1.79-127.78%
2007ยฃ6.44347.11%
2006ยฃ1.444.38%
2005ยฃ1.387.4%
2004ยฃ1.2843.03%
2003ยฃ0.9025.09%
2002ยฃ0.7252.67%
2001ยฃ0.4769.76%
2000ยฃ0.28